BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv6.5.5//EN
X-ORIGINAL-URL:https://compliance-calendar.sakiyomi.co.jp/
X-WR-CALNAME:Compliance Calendar
X-WR-CALDESC:
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
DTSTART;TZID=Asia/Tokyo:20260414T000000
DTEND;TZID=Asia/Tokyo:20260415T000000
DTSTAMP:20260417T000000
UID:MEC-0a7c5acfd5d2e3f8c5efb3a9f9f465f3@compliance-calendar.sakiyomi.co.jp
CREATED:20260418
LAST-MODIFIED:20260418
PRIORITY:5
TRANSP:OPAQUE
SUMMARY:米国｜FDA、遺伝子治療の開発促進に向け、ゲノム編集の安全基準に関するガイダンス案を発表
DESCRIPTION:\nFDA Issues Draft Guidance on Genome Editing Safety Standards to Advance Gene Therapy Development ( https://www.fda.gov/news-events/press-announcements/fda-issues-draft-guidance-genome-editing-safety-standards-advance-gene-therapy-development )\n
URL:https://compliance-calendar.sakiyomi.co.jp/events/%e7%b1%b3%e5%9b%bd%ef%bd%9cfda%e3%80%81%e9%81%ba%e4%bc%9d%e5%ad%90%e6%b2%bb%e7%99%82%e3%81%ae%e9%96%8b%e7%99%ba%e4%bf%83%e9%80%b2%e3%81%ab%e5%90%91%e3%81%91%e3%80%81%e3%82%b2%e3%83%8e%e3%83%a0/
CATEGORIES:ゲノム・DNA操作,セクター,化学物質,医療・医薬品,医薬品,注目領域
ATTACH;FMTTYPE=image/png:https://compliance-calendar.sakiyomi.co.jp/wp-content/uploads/2023/09/wide-medical-150x150-1.png
END:VEVENT
END:VCALENDAR